Gene therapy injection tested to halt rapid blindness
NCT ID NCT02652767
Summary
This study tested whether a single gene therapy injection (called GS010) into the eye could improve or preserve vision in people with a rare, rapidly progressing form of inherited blindness (LHON). It involved 39 participants who had started losing vision within the last 6 months. The trial compared the real injection to a sham (pretend) procedure to see if the treatment was effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC, ATROPHY, HEREDITARY, LEBER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre National Hospitalier d'Ophtalmologie des Quinze-VingtCentre National Hospitalier d'Ophtalmologie des Quinze-Vingt
Paris, Paris, France
-
Department of Neurology, University of Munich, Friedrich-Baur-Institute
Munich, 80336, Germany
-
Department of Ophthalmology, Emory University School of Medicine
Atlanta, Georgia, 30322, United States
-
Doheny Eye Center, University of California, Los Angeles
Los Angeles, California, 91105, United States
-
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Ospedale Bellaria
Bologna, Bologna, Italy
-
Moorfields Eye Hospital NHS Foundation Trust
London, EC1V 2PD, United Kingdom
-
Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.